Develops pain relievers for chronic pain and autoimmune diseases.
Jun 2026Revenue $161K/yrExpenses $1.80M/yr
No trend
Figures by year
When will Nutra Pharma be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $161K and expenses $1.80M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $258K | $1.72M | −$1.46M |
| Dec 2024 | $246K | $1.12M | −$878K |
| Dec 2023 | $206K | $1.09M | −$887K |
| Dec 2022 | $146K | $2.05M | −$1.91M |
| Dec 2021 | $97.7K | $2.09M | −$1.99M |
| Dec 2020 | $51.9K | $977K | −$925K |
| Dec 2019 | $104K | $1.33M | −$1.23M |
| Dec 2018 | $131K | $2.01M | −$1.88M |
| Dec 2017 | $121K | $1.50M | −$1.38M |
| Dec 2016 | $168K | $2.21M | −$2.04M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.